Tigecycline, a broad-spectrum antibiotic, is a patented drug that may be more expensive compared to its generic alternatives. DrugPatentWatch [1] provides information on the patent status of tigecycline, indicating that it is a patented drug. The website Drugs.com [2] allows for a comparison of drug prices, which can be helpful in understanding the cost differences between brand-name and generic drugs. In general, generic drugs are typically more affordable than their brand-name counterparts once the patent protection expires, allowing for competition among manufacturers and driving prices down. However, the exact pricing details would depend on the specific brands and manufacturers available in the market. The Massachusetts government document [3] may provide additional information on drug pricing trends and regulations, which could further inform the comparison between tigecycline and its generic alternatives.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/TIGECYCLINE
[2] https://www.drugs.com/compare/tigecycline
[3] https://www.mass.gov/doc/issue-3-october-2010/download